• Address:

    2803 Philadelphia Pike B
    # 4081 Claymont, DE 19703

  • Mail us:

    support@pragmajournals.org

  • Submit

Journal of Vaccines and Immunopathology

Journal of Vaccines and Immunopathology (JVI)

Pathogen and Pathogenesis explain the biological origin of various diseases and they affect our immune system. Although inbuilt body mechanism develops antibodies to fight these Pathogens, vaccines are essential to prevent the disease causing bacteria and the virus from entering our body and damaging our immune system. Vaccines and the immunology are thus closely associated with each other and the Journal of Vaccines and Immunopathology tries to capture all the latest developments in this field on open access platform. With the advancements in ICTs, immunotherapy as a field of study made tremendous progress in the diagnosis, therapy and cure. Researchers across the globe are engaged in vaccine research to fight various seasonal and contagious diseases that are life threatening. This peer reviewed journal highlights all these developments by publishing original research as journal articles. 

Latest Articles

COVID-19 Vaccine Acceptance in India: Early Experiences and lessons From Adult Immunization, H1N1 Pandemic and Seasonal Influenza Vaccination

Article Type: Review Article
Authors:

Manoja Kumar Das*

With no definite therapeutic or preventive drug against COVID-19 virus, vaccine is critical to disrupt the pandemic. Two vaccines have received emergency use authorization in America and Europe and two vaccine in India. Indian introduced COVID-19 vaccination on January 16, 2021. Despite severe disruption of the lifestyle, socioeconomic activities and ongoin restrictions, vaccine hesitancy is anticipated. While the vaccine introduction is in progress, the vaccine hesitancy needs to be considered based on the past experiences on pandemic and adult immunization drives. The initial experiences in India has been uneven with lower performance in some progressive states. Special targeted efforts are needed to tackle the vaccine hesitancy and improve public confidence for effective implementation

DOI: 10.47755/J Vaccines Immuno Pathol (2021): 1; 001-006
INDEXING
PARTNERS